Back to search

Article

KRAS Inhibitors Are Potential Prophylaxis for Colorectal Cancer Metachronous Metastasis

2024-03-21

Abstract excerpt

Colorectal cancer (CRC) with KRAS mutation is prone to develop metachronous metastasis. However, effective measures for prediction and prevention of such clinical issue are currently unavailable. In this study, we confirmed that KRAS mutation is a risk factor for CRC metachronous metastasis through meta-analysis and public database analysis. Based on the ICGC-AGRO database, we have constructed a risk scoring model...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8354efa6-096f-5753-a03a-1c0b95c97c4a
DOI
10.20944/preprints202403.1095.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
KRAS Inhibitors Are Potential Prophylaxis for Colorectal Cancer Metachronous MetastasisDOI 10.20944/preprints202403.1095.v1
Select a neighboring publication to make it the new centre.